A widely used and affordable medication for gout might also help reduce heart attacks and strokes in people with heart ...

The drug colchicine may reduce cardiovascular outcomes among patients with gout, based on a range of retrospective data that suggest improved outcomes and mechanistic connections between gout and ...

A low dose of a cheap drug commonly used to treat gout could significantly slash the risk of heart attack and stroke in people with existing heart problems, according to new research. Colchicine, a ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — The use of colchicine for gout flare prevention imparts a “modest” decrease in the risk for knee or ...

Colchicine, a cheap and widely used gout drug, may help prevent heart attacks and strokes in people with cardiovascular disease. Trials involving nearly 23,000 patients show meaningful reductions in ...

Share on Pinterest Scientists have repurposed a common gout drug to see if it helps reduce heart attacks and strokes in people with cardiovascular disease. Design by MNT; Photography by Eversame, CC ...

Gout is the most common form of inflammatory arthritis, with a worldwide prevalence of approximately 4%. The accumulation of monosodium urate crystals in gout leads to the clinical manifestations of ...

Patients with gout are commonly prescribed colchicine prophylaxis, despite already taking medications that could potentially interact. Patients with gout are commonly prescribed colchicine prophylaxis ...

The media reports that colchicine, a very old drug, has now been discovered to reduce the risk of recurrent heart disease and has a new FDA indication. Of course, the “discovery” has taken 10 years, ...

Please provide your email address to receive an email when new articles are posted on . The 2010 increase in colchicine prices was immediately followed by a decrease in the drug’s use for gout.

Depending on one’s perspective, the anti-inflammatory colchicine is either an unsung and underprescribed drug for patients with cardiovascular disease, or it’s an agent with limited clinical benefit ...